CRIPTO antagonist ALK4L75A-Fc inhibits breast cancer cell plasticity and adaptation to stress.

Balcioglu O, Heinz RE, Freeman DW, Gates BL, Hagos BM, Booker E, Mirzaei Mehrabad E, Diesen HT, Bhakta K, Ranganathan S, Kachi M, Leblanc M, Gray PC, Spike BT. CRIPTO antagonist ALK4L75A-Fc inhibits breast cancer cell plasticity and adaptation to stress. Breast Cancer Res. 2020 11 13; 22(1):125.

View in: PubMed

subject areas

Activin Receptors, Type I
Animals
Cell Line, Tumor
Cell Plasticity
Endoplasmic Reticulum Stress
Female
GPI-Linked Proteins
Humans
Immunoglobulin Fc Fragments
Intercellular Signaling Peptides and Proteins
Mice
Neoplasm Proteins
Neoplasm Recurrence, Local
Neoplastic Stem Cells
Point Mutation
Protein Binding
Protein Domains
Recombinant Fusion Proteins
Triple Negative Breast Neoplasms
Tumor Hypoxia
Tumor Microenvironment
Xenograft Model Antitumor Assays

authors with profiles

Brooke Lianne Gates